UC launches gene therapy trial to transform the treatment of sickle cell disease
By Lisa M. Krieger,
The Mercury News
| 03. 31. 2021
CRISPR gene editing corrects the defect that causes blood disease
"Sickle cell disease (SCD)" by National Institutes
of Health (NIH) is licensed under CC BY-NC 2.0
A team of University of California scientists are launching a first-ever human study of a powerful new gene-editing technique to fix the bad gene that causes sickle cell disease, offering the promise of a cure for the devastating blood illness.
On Tuesday, researchers announced that they have received U.S. Food and Drug Administration approval to test the approach, using a technique called CRISPR-Cas9, at UCSF Benioff Children’s Hospital Oakland and UCLA’s Broad Stem Cell Research Center.
“Our goal is to be able to deliver a safe and effective therapy that we can administer as soon as we know the diagnosis — and spare those children and young adults all the complications of this disorder.” said Dr. Mark Walters, a professor of pediatrics at UCSF and principal investigator of the project.
For 65 years, scientists have known the cause of sickle cell disease but have been unable to cure it without a bone marrow transplant. By fixing the underlying genetic problem, the new research buoys...
Related Articles
By Hannah Devlin, The Guardian | 07.05.2025
Scientists are just a few years from creating viable human sex cells in the lab, according to an internationally renowned pioneer of the field, who says the advance could open up biology-defying possibilities for reproduction.
Speaking to the Guardian, Prof...
By Maoli Duan, The Conversation | 07.02.2025
By Alice Park, TIME | 07.08.2025
Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to appear soon after birth.
To date, there haven’t been many reliable treatment options for these babies. The few that do exist involve...
By Jessica Hamzelou, MIT Technology Review | 07.18.2025
This week we heard that eight babies have been born in the UK following an experimental form of IVF that involves DNA from three people. The approach was used to prevent women with genetic mutations from passing mitochondrial diseases to...